NJ State Employees Deferred Compensation Plan - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 249 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$1,740,805
+87.2%
5,5000.0%0.24%
+70.2%
Q3 2023$929,995
-22.0%
5,5000.0%0.14%
-18.0%
Q2 2023$1,192,675
+19.4%
5,5000.0%0.17%
+11.7%
Q1 2023$999,020
+64.0%
5,500
+77.4%
0.15%
+55.6%
Q4 2022$609,150
-12.6%
3,1000.0%0.10%
-16.8%
Q3 2022$697,0003,1000.12%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,885,602$135,763,00012.56%
PFM Health Sciences, LP 499,510$35,965,0002.95%
Eventide Asset Management 901,077$64,878,0002.10%
ACUTA CAPITAL PARTNERS, LLC 56,000$4,032,0001.95%
Logos Global Management LP 69,658$5,015,0001.91%
Vivo Capital, LLC 223,692$16,106,0001.46%
Atika Capital Management LLC 90,000$6,480,0001.24%
EAM Global Investors LLC 27,126$1,953,0001.14%
EAM Investors, LLC 40,516$2,917,0000.91%
MOODY ALDRICH PARTNERS LLC 25,844$1,861,0000.56%
View complete list of KARUNA THERAPEUTICS INC shareholders